These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34353031)

  • 21. [Comprehensive rehabilitation of individualized exercise program for coal workers pneumoconiosis in Huaibei Coal Mine Group].
    Xiao K; Liu JH; Ding XP; Cui FT; Wang HB; Wang MM; Shen FH
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2019 May; 37(5):357-361. PubMed ID: 31177714
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical activity decline is disproportionate to decline in pulmonary physiology in IPF.
    Prasad JD; Paul E; Holland AE; Glaspole IN; Westall GP
    Respirology; 2021 Dec; 26(12):1152-1159. PubMed ID: 34448321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial.
    Guo S; Song Y; Feng J; Liu S; Li Y; Liu M; Wei L; Zhang X; Xie H; Sun Z
    J Tradit Chin Med; 2020 Aug; 40(4):674-682. PubMed ID: 32744035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.
    Ryerson CJ; Camp PG; Eves ND; Schaeffer M; Syed N; Dhillon S; Jensen D; Maltais F; O'Donnell DE; Raghavan N; Roman M; Stickland MK; Assayag D; Bourbeau J; Dion G; Fell CD; Hambly N; Johannson KA; Kalluri M; Khalil N; Kolb M; Manganas H; Morán-Mendoza O; Provencher S; Ramesh W; Rolf JD; Wilcox PG; Guenette JA
    Ann Am Thorac Soc; 2016 Sep; 13(9):1640-7. PubMed ID: 27348402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review.
    Swigris JJ; Esser D; Conoscenti CS; Brown KK
    Health Qual Life Outcomes; 2014 Aug; 12():124. PubMed ID: 25138056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Nishimura K; Nishiyama O; Sakamoto K; Hasegawa Y
    Intern Med; 2017; 56(13):1637-1644. PubMed ID: 28674350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of respiratory muscle strength and its influence on exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis.
    Pehlivan E; Zeren M; Niksarlıoğlu EY; Karaahmetoğlu FS; Özcan ZB; Balcı A; Demirkol B; Çetinkaya E
    Sarcoidosis Vasc Diffuse Lung Dis; 2024 Jun; 41(2):e2024028. PubMed ID: 38940715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis-A Single-Center Randomized Trial.
    Cerdán-de-Las-Heras J; Balbino F; Løkke A; Catalán-Matamoros D; Hilberg O; Bendstrup E
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary Rehabilitation in Patients With Advanced Idiopathic Pulmonary Fibrosis Referred for Lung Transplantation.
    da Fontoura FF; Berton DC; Watte G; Florian J; Schio SM; Camargo JJP; Teixeira PJZ; Moreira JDS
    J Cardiopulm Rehabil Prev; 2018 Mar; 38(2):131-134. PubMed ID: 29465499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
    Bodlet A; Maury G; Jamart J; Dahlqvist C
    Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis.
    Hsieh MJ; Lee WC; Cho HY; Wu MF; Hu HC; Kao KC; Chen NH; Tsai YH; Huang CC
    Influenza Other Respir Viruses; 2018 Sep; 12(5):643-648. PubMed ID: 29676537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis.
    Chambers DC; Enever D; Ilic N; Sparks L; Whitelaw K; Ayres J; Yerkovich ST; Khalil D; Atkinson KM; Hopkins PM
    Respirology; 2014 Oct; 19(7):1013-8. PubMed ID: 25039426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relation between pulmonary ventilation parameters, exercise tolerance and quality of life in patients with chronic obstructive lung disease].
    Chlumský J; Stĕrbová L; Smolíková L; Matous M; Salajka F
    Vnitr Lek; 2002 Apr; 48(4):320-4. PubMed ID: 12061182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the IPF-specific version of St. George's Respiratory Questionnaire.
    Prior TS; Hoyer N; Shaker SB; Davidsen JR; Yorke J; Hilberg O; Bendstrup E
    Respir Res; 2019 Aug; 20(1):199. PubMed ID: 31462235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric properties of the St George's Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis.
    Swigris JJ; Esser D; Wilson H; Conoscenti CS; Schmidt H; Stansen W; Leidy NK; Brown KK
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28100551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
    King TE; Behr J; Brown KK; du Bois RM; Lancaster L; de Andrade JA; Stähler G; Leconte I; Roux S; Raghu G
    Am J Respir Crit Care Med; 2008 Jan; 177(1):75-81. PubMed ID: 17901413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.
    Kreuter M; Wuyts WA; Wijsenbeek M; Bajwah S; Maher TM; Stowasser S; Male N; Stansen W; Schoof N; Orsatti L; Swigris J
    Respir Res; 2020 Jan; 21(1):36. PubMed ID: 32000772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evidence for improving exercise tolerance and quality of life with pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Lei S; Li X; Xie Y; Li J
    Clin Rehabil; 2022 Aug; 36(8):999-1015. PubMed ID: 35481421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Improvement and Effectiveness of Exercise-Based Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis: A BRIEF ANALYTICAL REVIEW.
    Vainshelboim B
    J Cardiopulm Rehabil Prev; 2021 Jan; 41(1):52-57. PubMed ID: 33186196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.